NASDAQ Rolls On To 10 Year High At 3016 Up 1%
Biotech Sector (IBB $119.73) Up 12 % YTD, Lagging NASDAQ (QQQ) Up 17.85% Here is a summary of our recommendations over the past month: No change in our basic Rayno Life Science Portfolios.Biopharmaceuticals have outperformed Tools and Diagnostics. Continued strength with following stocks at...
Snow Blog West: Snowy Period by March 17th
All the Models Looking Better for PPT We should see a change by next weekend for one of the worst Sierra seasons in recent times. Mammoth has a good base due to excellent man made snow, but has received only 157 in. of snow season TD compared to an average of 342 in., and the following snowfall...
Biotech Stocks Ignited on JNJ Prostate Drug Study
Biotech Sector Recovers from Monday's Weakness-Bull Intact Biotech stocks are strong today tracking a NASDAQ rally and favorable news on JNJ's prostate drug Zytiga which met its goal in a new study. Dendreon stock took a big hit down 10% because the JNJ therapy is simpler and cheaper, while...
Illumina (ILMN $50.35) Good Value
CEO Jay Flatley was on CNBC at 4:55p today with Maria Bartiromo. Maria asked him why the Company did not accept the Roche offer? He answered " because the offer was near the stock's low for the year and was opportunistic and did not reflect the value of the Company." Flatley also reiterated...
Sell-Off Picks Up With Some Biotechs Hit Hard
Smaller Cap Biotechs In Major Correction All the major indices are down in the 1.75% range and now the NASDAQ at 2902 is 100 pts. away from the elusive 3000 level. Analysts have been warning about a correction for weeks but with many indices up 10-15% YTD profit taking was inevitable. Driving...